FDA Approved: TREXIMET — Original Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

FDA approved TREXIMET, a fixed-dose combination of sumatriptan succinate and naproxen sodium, under an original application by Currax Pharmaceuticals LLC for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

ORIG AP for TREXIMET (SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM)